Skip to main content
EXCELSIOR logo

EXCELSIOR — Investor Relations & Filings

Ticker · 4104 ISIN · TW0004104005 TW Human health and social work activities
Open in API
Filings indexed 1,662 across all filing types
Latest filing 2021-09-09 Director's Dealing
Country TW Taiwan
Listing TW 4104

About EXCELSIOR

www.excelsiormedical.com.tw

Excelsior Medical Co., Ltd. is a comprehensive medical service provider specializing in the distribution and integration of medical equipment and healthcare solutions. Originally established as a distributor of hemodialysis consumables, the company has evolved into a diversified healthcare group. Its core business activities encompass the supply of specialized medical products, including hemodialysis and plasma exchange systems, blood bags, artificial stoma products, and scar care solutions. Beyond clinical equipment, the company provides hospital management services and operates in sectors such as respiratory therapy, ophthalmology, rehabilitation, and long-term care. Excelsior Medical also distributes premium health appliances and medical aesthetic products, catering to both professional medical institutions and consumer markets. By integrating innovative technologies with systematic management, the company delivers customized healthcare solutions.

Recent filings

Filing Released Lang Actions
110年08月內部人持股異動(事後)
Director's Dealing Classification · 100% confidence The document is a detailed tabular disclosure of shareholdings by insiders, including directors, chairpersons, and executives, showing their stock ownership, changes in holdings, and related notes. It is a typical insider shareholding report, listing personal and related party holdings, increases, decreases, and trust shares. There is no indication of financial statements, earnings data, or management discussion. The document is not an announcement of a report but a direct disclosure of insider share transactions or holdings. This matches the definition of Director's Dealing (DIRS), which covers reports of personal share transactions by company directors and executives (insider trades). The document length is about 9,901 characters, sufficient for a detailed insider shareholding report. Therefore, the correct classification is DIRS.
2021-09-09 Chinese
110年08月董事會成員及持股
Director's Dealing Classification · 95% confidence The document is a detailed tabulation of shareholdings by company insiders, including directors, supervisors, and senior management, showing their current and pledged shares. It includes specific data on share counts and relationships but does not contain financial statements, earnings data, or report narratives. The content aligns with disclosures about insider shareholdings and transactions rather than financial results or corporate governance changes. This matches the definition of Director's Dealing (DIRS), which covers reports of personal share transactions by company directors and executives (insider trades). The document length is 2538 characters, which is consistent with a detailed insider shareholding report rather than a brief announcement or a full financial report. Therefore, the appropriate classification is DIRS with high confidence.
2021-09-09 Chinese
110年8月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a listed company, providing data on loan balances and guarantee endorsements for the current and previous months. It contains no narrative, no detailed financial statements, no management discussion, and no indication of a report publication or meeting materials. The content is regulatory in nature, reporting specific financial data points likely required by a regulatory body. The document length is short (628 characters), and it does not announce or attach a report but provides direct data. This fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory disclosures that do not fit other specific categories.
2021-09-09 Chinese
110年8月營業收入
Interim / Quarterly Report Classification · 90% confidence The document is a summary report of monthly and cumulative net operating revenue figures for a company named 佳醫, presented in a tabular format with explanations about accounting standards and reporting practices. It contains actual financial data for a specific month (August of year 110 in the Taiwanese calendar) and compares it to the previous year. The document length is short (775 characters) but it includes substantive financial data, not just an announcement or a certification. It is not a full annual or interim report but rather a periodic financial summary. Given the presence of monthly and cumulative revenue data, this fits best as an Interim / Quarterly Report (IR) rather than a simple earnings release or regulatory filing. Therefore, the classification is IR with high confidence. Q3 2021
2021-09-09 Chinese
110年第2季海外子公司投資
Regulatory Filings Classification · 85% confidence The document contains detailed financial data about investments in overseas subsidiaries, including shareholding percentages, original investment amounts, investment balances, and recognized investment gains or losses for the current period. It references accounting standards and provides a tabular breakdown of investment details. The document length is 1590 characters, which is relatively short and does not appear to be a full annual or interim report. It is not an announcement or a certification but rather a detailed financial disclosure related to investment accounting. Given the nature of the content focusing on investment accounting and financial data without being a full financial report, it best fits the category of Regulatory Filings (RNS), which is the fallback for miscellaneous financial disclosures that do not fit other specific categories.
2021-08-12 Chinese
110年第2季權益變動表
Interim / Quarterly Report Classification · 95% confidence The document contains detailed financial data including consolidated equity changes for the first half of the year 110 (which corresponds to 2021 in the ROC calendar) and the previous half-year period. It includes line items such as common stock capital, capital surplus, legal surplus reserve, special surplus reserve, undistributed earnings, retained earnings, foreign currency translation adjustments, and other comprehensive income items. The presence of detailed financial tables with actual figures for a half-year period indicates this is a substantive financial report for an interim period rather than a brief announcement or certification. The document length is 4697 characters, which is sufficient for a detailed interim report. The content matches the characteristics of an Interim / Quarterly Report (IR) as it provides comprehensive financial data for a period shorter than a full fiscal year (half-year). There is no indication that this is an announcement of a report or a certification letter, so it should not be classified as RPA or RNS. Therefore, the correct classification is IR with high confidence. H1 2021
2021-08-12 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.